Strength Profile of Hip Joint in Females With Primary Dysmenorrhea During Menstrual Cycle

NCT06615037 | Completed

• 1 other identifier: P.T.REC\012\005318
• Study Type: observational
• Target: 40
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this observational study is to investigate the effect of primary dysmenorrhea on strength of hip joint muscles in females.

Conditions

Primary Dysmenorrhea

Keywords

Dysmenorrhea; primary dysmenorrhea; Hip joint strength; isokinetic strength profile

Outcome Measures

Primary Outcomes (1)

• 1- Hip flexors isokinetic strength 2- Hip extensors isokinetic strength

  The Biodex isokinetic dynamometer (System 4 pro) will be used to assess the strength of hip flexors and extensors during different phases of menstrual cycle.

  3 months

Study Arms (2)

Group A: Symptomatic dysmenorrhea

According to WaLLID Scale Questionnaire

Other: Assess Hip joint strength by Biodex isokinetic dynamometer (System 4 Pro)

Group B: Asymptomatic dysmenorrhea

According to WaLLID Scale Questionnaire

Other: Assess Hip joint strength by Biodex isokinetic dynamometer (System 4 Pro)

Interventions

Assess Hip joint strength by Biodex isokinetic dynamometer (System 4 Pro) OTHER

Assessment of the strength of hip flexors and extensors muscles: * Participants will be in a supine-lying position, the highest reliability (ICC = 0.90) according to the results of the meta-analysis (Contreras et al., 2021). * Seat orientation 0°. * Dynamometer tilt 0° and orientation 0°. * The axis of the dynamometer on the greater trochanter of the femur. * The test parameters included a 0-90 degree range of motion. * During the isokinetic testing movement, the hip was first flexed from a neutral (starting) position to 90° (for hip flexion) and then the direction of the movement was reversed (for hip extension) * Angular speed at 120°/s which shows excellent reliability (ICC = 95%) with concentric contraction mode (Contreras et al., 2021) .

Group A: Symptomatic dysmenorrhea; Group B: Asymptomatic dysmenorrhea

Eligibility Criteria

• Age: 20 Years - 25 Years
• Gender Eligibility Details: Adult females Having a regular menstrual cycle (28 ± 7 days with no intermittent bleeding), No pathology related to the pelvis, Having no injury in the lower limb and Not consuming contraceptives, dietary supplements and steroid drugs.
• Healthy Volunteers: No
• Age Groups: Adult (18-64)
• Sampling Method: Non-Probability Sample

Study Population

44 adult females , age range: 20-25 years , BMI: 18-25 , 22 participants have symptomatic primary dysmenorrhea and 22 have asymptomatic primary dysmenorrhea according WaLLID Questionnaire

You may qualify if:

• Age range from 20 to 25 years.
• BMI ranges from 20 to 25 kg/m2.
• Having a regular menstrual cycle (28 ± 7 days with no intermittent bleeding).
• No pathology related to the pelvis.
• Having no injury in the lower limb.
• Not consuming contraceptives, dietary supplements and steroid drugs.

You may not qualify if:

• Menstrual irregularity.
• Pregnancy or suspicion of pregnancy.
• Having given birth.
• Using an intrauterine device.
• Oral contraceptives or antidepressant use.
• Having a diagnosis of secondary dysmenorrhea.
• Surgical history involving the abdominal region, pelvic region, and/or the spine in the last year.
• Having musculoskeletal problems related to lower extremities.
• Having any psychiatric or gynecological problems.
• Suffering from premenstrual syndrome.

Sponsors & Collaborators

• Cairo University: lead

Study Sites (1)

Cairo University

Giza, 12511, Egypt

Location

MeSH Terms

Conditions

Dysmenorrhea

Condition Hierarchy (Ancestors)

Menstruation Disturbances; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Pelvic Pain; Pain; Neurologic Manifestations; Signs and Symptoms

Study Officials

• Nourhan Mohamed Mitwally Amer

  Bachelor Physical Therapy- MUST

  PRINCIPAL INVESTIGATOR

• Amal Mohamed Yousef, Professor

  Cairo University

  STUDY CHAIR

• Mai Mohamed Ali, Lecturer

  Cairo University

  STUDY DIRECTOR

• Ehab Kamal Mohamed Younis, lecturer

  Lecturer of obstetrics and gynecology - Faculty of Medicine - Misr university for science and technology

  STUDY DIRECTOR

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principle Investigator

Study Record Dates

• First Submitted: September 24, 2024
• First Posted: September 26, 2024
• Study Start: October 1, 2024
• Primary Completion: January 15, 2025
• Study Completion: January 15, 2025
• Last Updated: February 5, 2025

Record last verified: 2025-02

Locations

EG (1)